Jason C Dugas

Title: Jason C Dugas: Innovator in Antibody Development

Introduction

Jason C Dugas is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Dugas holds a patent for "Phospho-Rab antibodies, assays and methods of use thereof." This patent includes antibodies that specifically bind to phosphorylated Rab proteins. Notably, one embodiment features a monoclonal antibody that targets the phosphorylated human Rab10 protein, recognizing an epitope within the sequence AGQERFH(pT)ITTSYYR (SEQ ID NO:123). Additionally, another embodiment involves a monoclonal antibody that binds to the phosphorylated human Rab8a protein, recognizing the epitope QERFR(pT)ITTAY (SEQ ID NO:125). His patent also provides methods and materials for detecting LRRK2 and Rab proteins.

Career Highlights

Dugas is currently associated with Denali Therapeutics Inc., where he continues to advance his research and development efforts. His work at Denali Therapeutics focuses on innovative solutions in the biotechnology sector, contributing to the company's mission of developing therapies for neurodegenerative diseases.

Collaborations

Throughout his career, Dugas has collaborated with notable colleagues, including Xiang Wang and Nathan Moerke. These collaborations have enhanced the research and development process, leading to significant advancements in their respective fields.

Conclusion

Jason C Dugas exemplifies the spirit of innovation in biotechnology through his patent on phospho-Rab antibodies and his work at Denali Therapeutics Inc. His contributions are vital to the ongoing development of targeted therapies in medicine.